Inactief instrument

Koers Avanir Pharmaceuticals Inc

Aandelen

slotkoers Nasdaq Andere beurzen
- ^USD	-

Avanir Pharmaceuticals : Announces Appointment of Rohan Palekar as President and Chief Executive Officer	20-01-16
Avanir Pharmaceuticals : Announces Initiation of Phase III Trial of AVP-786 for Agitation in Patients with Alzheimer’s Disease	10-12-15
Avanir Pharmaceuticals : Announces JAMA Publication of Phase II Study Results Showing AVP-923 Significantly Reduced Agitation in Patients with Alzheimer's Disease	22-09-15
Avanir Pharmaceuticals : Prevails in NUEDEXTA® Patent Appeal Maintaining Exclusivity Through 2026	11-08-15
Avanir Pharmaceuticals : Announces New Findings from Dementia/Alzheimer's Disease Cohort of PRISM II Study at Alzheimer's Association International Conference	23-07-15

Managers	Titel	Leeftijd	Van
Dan Dalton CMP	Compliance Officer	-	01-06-16
Kelly Parker IRO	Public Communications Contact	-	01-06-15
Aneta Ferguson LAW	General Counsel	-	01-01-15

Besturend	Titel	Leeftijd	Van
Donald Hayden CHM	Chairman	68	-
Robert McQuade BRD	Director/Board Member	67	-
Thomas DesRosier BRD	Director/Board Member	69	-

Sector

	Vaira. 1 jan.	Kapi.
VERTEX PHARMACEUTICALS INCORPORATED	+3,91%	109 mld.
REGENERON PHARMACEUTICALS, INC.	+10,87%	105 mld.
ARGENX SE	+1,28%	22,25 mld.
BIONTECH SE	-13,14%	22,09 mld.
GENMAB A/S	-7,05%	18,68 mld.
WUXI APPTEC CO., LTD.	-38,36%	17,58 mld.
BEIGENE, LTD.	-10,66%	16,85 mld.
NEUROCRINE BIOSCIENCES, INC.	+3,75%	13,76 mld.
SAREPTA THERAPEUTICS, INC.	+36,70%	12,46 mld.